Atheroclerosis is a major cause of morbidity and mortality in insulin-resistant states such as metabolic? syndrome and obesity. Defective regulation of macrophage lipid metabolism plays a central role in the? development of vascular lesions associated with these dyslipidemic states. During atherogenesis,? macrophages respond to the challenge of lipid excess through enzymatic production of oxysterols and? activation of feed-forward nuclear receptor pathways that induce transcriptional programs involved in lipid? uptake and efflux, and negatively regulate inflammatory responses. In recent studies, we have shown that? the products of the Niemann-Pick type C (NPC) disease genes, NPC1 and NPC2, are required for delivery of? lipoprotein-derived cholesterol to sites of intracellular oxysterol synthesis. In this proposal, we will test the? hypothesis that macrophage-derived oxysterols play a critical role in the regulation of lipid? homeostasis in the vascular wall. We propose that impaired synthesis of side-chain oxygenated sterols? will reduce cholesterol efflux and increase cholesterol accumulation in macrophages, and, in concert with? increased levels of oxidized cholesterol, promote cytotoxicity and lesion formation. Production of specific? macrophage-derived cholesterol metabolites additionally may play a critical role in governing plasma? lipoprotein levels through regulation of hepatic lipoprotein synthesis and/or clearance of plasma lipoproteins.? This hypothesis will be tested by the following specific aims:? 1) To determine whether macrophage-specific NPC1 and NPC2 loss of function alters macrophage oxysterol? synthesis, thereby disrupting lipid homeostasis and promoting atherosclerosis in a murine model,? 2) To determine whether macrophage-derived cholesterol metabolites affect regulation of plasma lipoprotein? levels in chimeric mice with macrophage-specific NPC1 and NPC2 loss of function, and? 3) To assess the relationship between plasma oxysterol levels and coronary heart disease and determine if? oxysterol levels change following weight loss in humans with the metabolic syndrome.? These studies will contribute to our understanding of the role of macrophage-derived cholesterol? metabolites in atherogenesis and regulation of lipoprotein metabolism. This project has the potential to? transform the care of people with the metabolic syndrome by establishing these metabolites as novel? biomarkers for detection of subclinical atherosclerotic disease.
| Jamis-Dow, Carlos A; Barbier, George H; Watkins, Mary P et al. (2014) Bicuspid Pulmonic Valve and Pulmonary Artery Aneurysm. Cardiol Res 5:83-84 |
| Airhart, Nathan; Brownstein, Bernard H; Cobb, J Perren et al. (2014) Smooth muscle cells from abdominal aortic aneurysms are unique and can independently and synergistically degrade insoluble elastin. J Vasc Surg 60:1033-41; discussion 1041-2 |
| Thatcher, Sean E; Zhang, Xuan; Howatt, Deborah A et al. (2014) Angiotensin-converting enzyme 2 decreases formation and severity of angiotensin II-induced abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 34:2617-23 |
| Jin, Jianping; Arif, Batool; Garcia-Fernandez, Francisca et al. (2012) Novel mechanism of aortic aneurysm development in mice associated with smoking and leukocytes. Arterioscler Thromb Vasc Biol 32:2901-9 |
| Razani, Babak; Feng, Chu; Coleman, Trey et al. (2012) Autophagy links inflammasomes to atherosclerotic progression. Cell Metab 15:534-44 |
| Jiang, Xuntian; Sidhu, Rohini; Porter, Forbes D et al. (2011) A sensitive and specific LC-MS/MS method for rapid diagnosis of Niemann-Pick C1 disease from human plasma. J Lipid Res 52:1435-45 |
| Wei, Xiaochao; Schneider, Jochen G; Shenouda, Sherene M et al. (2011) De novo lipogenesis maintains vascular homeostasis through endothelial nitric-oxide synthase (eNOS) palmitoylation. J Biol Chem 286:2933-45 |
| Razani, Babak; Zhang, Haixia; Schulze, P Christian et al. (2011) Fatty acid synthase modulates homeostatic responses to myocardial stress. J Biol Chem 286:30949-61 |
| Porter, Forbes D; Scherrer, David E; Lanier, Michael H et al. (2010) Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease. Sci Transl Med 2:56ra81 |
| Marquart, Tyler J; Allen, Ryan M; Ory, Daniel S et al. (2010) miR-33 links SREBP-2 induction to repression of sterol transporters. Proc Natl Acad Sci U S A 107:12228-32 |
Showing the most recent 10 out of 28 publications
